Monographie - Omeprazole sodium

Ultimo aggiornamento :
08/05/2024

Omeprazole sodium

Struttura chimica

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Antra	Germania, Italia, Svizzera
Biomezol	Ecuador
Cezole	Perù
Ciplaprazole	Colombia
Dinsadrix	Messico
Fendiprazole	Argentina
Finulcer	Messico
Fordex	Venezuela
Gaspiren	Brasile
Gastromax	Venezuela
Gerdex	Messico
Haitrax	Messico
Helicid	Polonia
Imaroz	Chile
Inhibitron	Messico
Ipproton	Arabia Saudita, Tunisia
Klomeprax	Argentina, Ecuador
Lordin	Grecia
Losec	Arabia Saudita, Austria, Belgio, Gran Bretagna, Italia, Paesi Bassi, Polonia, Turchia
Mepral	Italia
Omeprazen	Italia
Omeprazol	Germania
Omeprazole	Francia
Oprazole	Arabia Saudita
Penrazol	Grecia
Rizek	Arabia Saudita
Timezol	Argentina
Ulcozol	Argentina
Ultop	Croazia

Bibliografia : Omeprazole sodium

	Tipo	Pubblicazione
186	Rivista	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
264	Rivista	Leboucher G, Charpiat B. Incompatibilité physico-chimique entre l’oméprazole et la vancomycine. Pharm Hosp Fr 1997 ; 121: 124.
1703	Rivista	Schuster F, Bernard R. Kompatibilität von enalaprilat i.v. mit ausgewählten arzneimitteln. Krankenhauspharmazie 1995 ; 16: 101-103.
2231	Rivista	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2311	Rivista	Kambia N.K, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion. J Clin Pharm Ther 2009 ; 34: 25-31.
3332	Laboratorio	Tigecycline (Tigacyl®) - Summary of Product characteristics Pfizer 2012
3658	Laboratorio	Omeprazole - Summary of Product Characteristics. Sandoz 2014
3823	Rivista	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.
3871	Poster	Soussi M.A, Soualah-alila R, jenene F, Lazreg O, Razgallah Khrouf M. Peut-on administrer le céfotaxime en Y avec d'autres médicaments injectables ? Synprefh Congress Clermont Ferrand, France 2016
3976	Rivista	Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B. Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
3985	Poster	Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M. Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro. Hopipharm Congress 2017 - Nancy 2017
4316	Rivista	Carpenter J.F, McNulty M-A, Dusci L.J, Ilett K.F. Stability of Omeprazole Sodium and Pantoprazole Sodium Diluted for Intravenous Infusion. J Pharm Technol 2006 ;22:95-98.
4642	Poster	Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia. SEFH Congress (Virtual) October 2021 2021

Mentions Légales